The Management Board of the European Medicines Agency (EMA) met on 14 and 15 December in Amsterdam. It adopted the Agency’s multiannual programming document for the period 2023-2025, which includes the EMA’s work programme for 2023 and its budget for 2023. The Agency has announced a budget increase of 8.6% compared to 2022 (€458 million). A preliminary programming document for 2024-2026 was also adopted.
After the Covid-19 phase, the EMA plans to lift the business continuity measures...